Preclinical Research Graph

Dimension Research, since its foundation as the largest clinical research organization in Pakistan having ISO 9001:2015 certificate, performs multiple studies on therapeutic areas most commonly included Oncology, hepatology, neurology, epidemiology, infectious diseases etc,. More than 5000 patients have been enrolled from 196 sites in the studies of multi national and national companies conducted by Dimension Research in Pakistan. Dimension research as a remarkably active and successful CRO participated in many publications. One of them is ”Comprehensive molecular potraits of human breast tumors – The Cancer genome Atlas Network, Nature Vol 490, 4th Oct 2012 Pg 61-70”.

Phase Trials and Observational Studies

Dimension Research offers expertise in clinical and non-clinical services, conducting a wide range of clinical trials (Phase II, III, and IV/Post-marketing Surveillance studies, Observational studies, and Pharmacokinetics studies) across various therapeutic areas including Oncology, Infectious diseases, Vaccine, Covid Vaccination, Cardiology, Diabetes & Endocrinology, ENT, Gastroenterology/Hepatology, Gynecology, Hypertension, Medical Devices, Pediatrics, Pediatric Nutrition, Pulmonology, Herbal therapies and Pharmacovigilance. Since year 2010, We have consistently delivered these services to national and multinational pharmaceutical and herbal companies, establishing ourselves as a pivotal partner in the field.

Additionally, Dimension Research played a crucial role as a CRO in the ground breaking Phase III study for a Covid Vaccine, marking a milestone in Pakistan’s research history and representing one of our most significant achievements to date.